# CHARM Hepatocellular Carcinoma MEA Study

> **NCT07650773** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 4000 (estimated)

## Conditions studied

- HepatoCellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07650773
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2026-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650773, "CHARM Hepatocellular Carcinoma MEA Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*